Optimi Health Provides Progress Report On Year Of Commercialization
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 – Optimi Health Corp. (CSE:OPTI)(OTCQX:OPTHF)(FRA:8BN)(“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce ... [Read]
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
VANCOUVER, British Columbia, Aug. 16, 2022 – Optimi Health Corp. (CSE:OPTI)(OTCQX:OPTHF)(FRA:8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, ... [Read]